|
CDER Director’s Office May Take Over ‘Crisis’ Shortages Control
The FDA is considering elevating staff that deals with drug shortages from the Office of New Drugs to the Office of the Center Director, the agency says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives